1258494

MedImmune U.K. Limited — FEI 3004066112

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Liverpool (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)